Pfizer Venture Investments

Corporate VC New York, United States · Founded 2004

Website

Pfizer Ventures invests globally in innovative biopharmaceutical and platform technology companies advancing breakthrough therapeutics and transformative technologies aligned with Pfizer's core focus areas.

About Pfizer Venture Investments

Pfizer Venture Investments is the corporate venture arm of Pfizer, deploying from the pharmaceutical giant’s balance sheet to invest in life sciences companies aligned with Pfizer’s scientific and strategic priorities. The fund typically invests across therapeutics, platform technologies, drug discovery tools, digital health that intersects clinical trials or patient engagement, and adjacent areas where Pfizer’s R&D and commercial organizations see strategic relevance. Check sizes typically range from $1M to $10M as a syndicate participant in Series A through C rounds, occasionally larger, alongside dedicated life-sciences VCs. For healthcare founders, Pfizer Venture Investments is highly relevant if you are building a therapeutics, platform or research-tool company where Pfizer is a credible strategic partner and where a corporate investor’s presence on the cap table signals scientific validation rather than constraints. The firm is a poor fit for digital-only health businesses without a clear life-sciences angle, services businesses and consumer-only plays. Founders should be aware that corporate VC investment can carry strategic implications including ROFRs, competitive sensitivities and pace-of-decision considerations, so terms and information rights should be negotiated thoughtfully. Entry is best via warm introductions from existing portfolio CEOs, life-sciences-focused VCs already on the cap table, or scientific advisors with Pfizer relationships; the firm has well-known investment professionals discoverable through Crunchbase and LinkedIn. Cold outbound is generally less effective for life-sciences corporate VC; a co-investor introduction substantially improves response quality and timeline.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Share your experience

At a glance

Type Corporate VC

Stages Growth, Seed, Series A, Series B, Series C, Series D+

Check size $5M-$25M

Sub-verticals AI/ML in Healthcare, Biotech, Digital Health

HQ New York, United States

Founded 2004

Visit website

Healthcare AI tools backed by Pfizer Venture Investments

Tools made by companies in Pfizer Venture Investments's portfolio that we cover in the directory.

PrescriberPoint

Clinical Decision Support & Reference

PrescriberPoint provides AI-enabled prescribing tools, including medication lookup, comparison, savings, coverage checks, and a prior authorization solution, to help physicians get patients on therapy faster.

Free